期刊文献+

p38MAPK抑制剂对小鼠急性移植物抗宿主病的发生及小肠损伤的影响 被引量:2

Effects of p38MAPK inhibitor on the occurrence of acute GVHD and intestine damage after allogeneic hematopoietic stem cell transplantation in mice
原文传递
导出
摘要 目的探讨p38丝裂原激活的蛋白激酶(p38MAPK)抑制剂SB203580对小鼠异基因骨髓造血干细胞移植后急性移植物抗宿主病(aGVHD)的发生及小肠损伤的影响。方法用60只BALB/c小鼠作为受鼠,分为正常对照组、单纯照射组、模型组和干预组,每组15只。单纯照射组、模型组和干预组小鼠均接受7.5Gyy射线全身照射。C57BL/6小鼠作为供鼠,取其骨髓细胞及脾细胞经尾静脉输注给接受照射后的受鼠,建立小鼠aGVHD模型。干预组为aGVHD模型小鼠给予SB203580干预,末次给药48h后处死。模型组小鼠为aGVHD模型仅给予等量二甲基亚砜。移植后观察小鼠的一般状态和生存情况。移植后10d取各组小鼠小肠组织,采用RT-PCR、Westernblot及免疫组化方法检测磷酸化p38MAPK、Fas、FasL的表达。结果干预组小鼠的体重下降程度为(13.00±0.50)%,轻于模型组的(25.00±0.75)%,差异有统计学意义(P〈0.05);干预组小鼠的aGVHD的临床评分(3.33±0.82)低于模型组(6.33±1.36),差异有统计学意义(P〈0.05);干预组小鼠的小肠组织中磷酸化p38MAPK、Fas、FasL的相对表达水平分别为1.43±0.02、0.81±0.03、0.97±0.03,均显著低于模型组的1.76±0.05、1.52±0.04、1.48±0.04。结论SB203580可抑制aGVHD小鼠小肠组织中p38MAPK通路的活化,减少Fas和FasL信号通路所引起的细胞凋亡,有效减轻aGVHD的发生及靶器官小肠的损害。 Objective To explore the effects of p38MAPK inhibitor SB203580 (SB) on the occurrence of acute GVHD and intestine damage after allogeneic hematopoietie stem cell transplantation (allo-HSCT) in mice. Methods Sixty BALB/c mice, as recipients, were randomized to control group, irradiation group, model group and intervention group. C57BL/6 mice, as donors, were raised to prepare the bone marrow cells (BMCs) and spleen cells (SCs), which were injected into irradiated recipients mice by tail vein. Except control group, other groups accepted 7.5Gy total body irradiation. Model group and intervention group were infused with BMCs 5×10^6 and SCs 5×10^5 by less than 4 h after irradiation. SB was injected into intervention group by intraperitoneally, but only DMSO for model group. The general status and survival rate of each group were evaluated. The expression of p-p38MAPK, Fas and FasL in intestine were determined by RT-PCR, Western blot and immunohistochemistry (IHC). Results The weight changes of intervention group (13.00±0.50)% was significantly lighter than that of model group (25.00± 0.75)% (P〈0.05). The clinical score of acute GVHD in the intervention group (3.33±0.82) was significantly lower than that of model group (6.33±1.36) (P〈0.05). The expression levels of p-p38MAPK, Fas and FasL in small intestine of intervention group (1.43±0.02, 0.81±0.03, 0.97±0.03) were lower than those of model group (1.76±0.05, 1.52±0.04, 1.48±0.04). Conclusion SB inhibited the activation ofp38MAPK and Fas/ FasL signal pathway and alleviated the apoptosis of small intestine. And SB could relieve small intestine damages induced by allogeneic T lymphocytes.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2013年第8期673-678,共6页 Chinese Journal of Hematology
基金 国家自然科学基金(81171590) 江苏省青蓝工程人才计划
关键词 移植物抗宿主病 p38丝裂原活化蛋白激酶类抑制剂 小肠 Fas FAS配体 Graft versus host disease Inhibitors, p38 Mitogen-activated protein kinases Small intestine Fas Fas ligand
  • 相关文献

参考文献18

  • 1Cuenda A, Rousseau S. p38 MAP- kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta, 2007, 1773: 1358-1375.
  • 2Quan L,Jian Z, Ping Z, et al. Proteinase-activated receptor-l mediates allogeneic CD8 (+ ) T cell-induced apoptosis of vascu.lar endothelial cells. Med Oncol, 2009, 26: 379-385.
  • 3潘彬,曾令宇,程海,宋国梁,贾路,闫志凌,陈翀,徐开林.X射线和γ射线预处理对小鼠异基因骨髓移植后造血免疫重建的影响[J].中华放射医学与防护杂志,2011,31(3):260-263. 被引量:3
  • 4曹江,李莉,陈翀,曾令宇,李振宇,潘秀英,徐开林.基因工程化Treg细胞对小鼠异基因骨髓移植后急性移植物抗宿主病的作用[J].中华血液学杂志,2011,32(2):83-88. 被引量:6
  • 5Zhou WD, Yang HM, Wang Q, et al. SB203580, a p38 mitogen- activated protein kinase inhibitor, suppresses the development of endometriosis by down- regulating pro inflammatory cytokines and proteolytic factors in a mouse model. Hum Reprod, 2010, 25: 3110-3116.
  • 6Brown D, Hikim AP, Kovacheva EL, et al. Mouse model of testosterone- induced muscle fiber hypertrophy: involvement of p38 mitogen-activated protein kinase-mediated Notch signaling.J Endocrinol, 2009, 201: 129-139.
  • 7Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood, 1996, 88: 3230-3239.
  • 8de la Cruz-Morcillo MA, Valero ML, Callejas-ValeraJL, et al. p38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance. Oncogene, 2012, 31: 1073-1085.
  • 9NickJA, Young SK, Arndt PG, et al. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen- activated protein kinase.J Immunol, 2002, 169: 5260-5269.
  • 10Cappellini A, Tazzari PL, Mantovani I, et al. Antiapoptotic role of p38 mitogen activated protein kinase inJurkat T cells and normal human T lymphocytes treated with 8-methoxypso.ralenand uItraviolet-Aradiation. Apoptosis, 2005,10: 141-152.

二级参考文献49

  • 1孟筱坚,林茂芳,蔡真.受者特异性产生干扰素γ细胞与急性移植物抗宿主病的关系[J].中华血液学杂志,2006,27(2):95-98. 被引量:3
  • 2唐小龙,江振友,董军,刘小澄,蔡淑玉,肖瑞,卢燕茹.IL-6对血管内皮细胞活性及TFmRNA表达的影响[J].四川大学学报(医学版),2006,37(2):234-237. 被引量:5
  • 3Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys, 2005, 440:123-132.
  • 4Naji A, Desschaseaux F, Racadot E, et al. Induction of tissue factor expression on human umbilical vein endothelial cells by cell-specific HLA class Ⅰ antibody: preliminary data. Transplant Proc, 2005, 37 : 2892-2893.
  • 5Reverdiau-Moalic P, Watier H, Iochmann S. Human allogeneie lymphocytes trigger endothelial, cell tissue factor expression by a tumor necrosis factor-dependent pathway. Lab Clin Med, 1998, 132:530-540.
  • 6Tichelli A, Gratwohl A. Vascular endothelium as ‘novel' target of graft-versus-host disease. Best Pract Res Clin Haematol, 2008, 21:139-148.
  • 7Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: 1. The roles of minor H antigens and endotoxin. Blood, 1996, 88: 3230-3239.
  • 8Eyrich M, Burger G, Marquardt K, et al. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after routine bone marrow transplantation across minor histocompatibility antigen barriers. Biol Blood Marrow Transplant, 2005, 11:371-382.
  • 9Nomura S, Ishii K, Inami N, et al. Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation. Biol Blood Marrow Transplant, 2005, 14:766-774.
  • 10Spek CA. Tissue factor: from ‘just one of the coagulation factors' to a major player in physiology. Blood Coagul Fibrinolysis, 2004, 15 Suppl 1 :S3-10.

共引文献13

同被引文献33

  • 1叶丽萍,叶一秀,施兵,刘丽辉,金建刚,俞志勇,户江伟,陈虎.细胞因子在白血病异基因造血干细胞移植后移植物抗宿主病中的水平及其意义[J].放射免疫学杂志,2007,20(3):198-201. 被引量:3
  • 2Pourhoseingholi MA,Vahedi M,Baghestani AR.Burden of gastrointestinal cancer in Asia; an overview.Gastroenterol Hepatol Bed Bench,2015,8(1): 19-27.
  • 3de Martel C,Forman D,Plummer M.Gastric cancer: epidemiology and risk factors.Gastroenterol Clin North Am,2013,42(2): 219-240.
  • 4Maroon JC,Bost JW.Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain.Surg Neurol,2006,65(4): 326-331.
  • 5Kondrup J,Rasmussen HH,Hamberg O,et al.Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials.Clin Nutr,2003,22(3): 321-336.
  • 6Choi KS,Suh M.Screening for gastric cancer: the usefulness of endoscopy.Clin Endosc,2014,47(6): 490-496.
  • 7Harvey SE,Parrott F,Harrison DA,et al.Trial of the route of early nutritional support in critically ill adults.N Engl J Med,2014,371(18): 1673-1684.
  • 8Huhmann MB,August DA.Perioperative nutrition support in cancer patients.Nutr Clin Pract,2012,27(5): 586-592.
  • 9Horgan A.Pre-operative nutrition support in patients undergoing gastrointestinal surgery.Tech Coloproctol,2014,18(11): 1137-1138.
  • 10Nespoli L,Coppola S,Gianotti L.The role of the enteral route and the composition of feeds in the nutritional support of malnourished surgical patients.Nutrients,2012,4(9): 1230-1236.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部